Clinical evidence dossier
Exercise therapy
Tumor Necrosis Factor-alpha (TNF-α)
Evidence signal
Authoritative evidence signal
strong
This is an authoritative evidence signal supplied by Clinical Reference. It is not a formal clinical grade, treatment recommendation, or pooled effect estimate.
Evidence snapshot
- Authoritative support records
- 3
- Supporting studies available for review
- 3
- Randomized trials
- 3
- Reported effects
- 4
Clinical conclusion
Exercise therapy shows a moderate positive evidence signal for improving Tumor Necrosis Factor-alpha (TNF-α) across the studied comparisons.
The conclusion and evidence-signal classification are distinct authoritative fields and are reproduced as published.
Observed effects
Evidence composition
- Non-randomized studies
- 0
- Other designs
- 0
- Unresolved designs
- 0
- Magnitude-eligible effects
- 0
Consistency
Authoritative consistency classification
mostly_consistent
- Positive
- 2
- No effect
- 1
- Mixed
- 0
- Negative
- 0
Population and applicability
Structured population data were available for 3 of 3 supporting studies. 2 studies described participants with type 2 diabetes. 1 study described adult participants.
This population information refers to the materialized supporting studies available for review. Omitted support records remain part of the authoritative support accounting and are available through the audit experience.
View reported population descriptions
These descriptions are reported across the supporting studies; they are not a single synthesized population.
- Obese women aged 30-60 with type 2 diabetes.
- Individuals seeking alternative methods to manage diabetes.
- Patients interested in combining dietary supplements with exercise.
- Adults with multimorbidity, including chronic conditions such as hypertension and diabetes.
- Individuals seeking non-pharmacological interventions to manage blood pressure.
- Women aged 30-60 with type 2 diabetes
- Individuals experiencing exercise-induced muscle soreness and fatigue
Limitations
- 1 supporting study does not have a displayable topic-matched quantitative effect.
- Evidence uses heterogeneous comparison contexts: placebo, usual_care.
- 2 of 3 studies with duration data have follow-up of 12 weeks or less.
Supporting evidence
Inspect the authoritative studies and omitted support records for this dossier.